Screening CRC patients for Lynch syndrome 'cost-effective'

Extensive Australian analysis suggests screening by testing for DNA mismatch repair deficiency

Screening all cases of incident colorectal cancer in Australia for Lynch syndrome would be cost-effective, and save about 80 deaths a year, according to the most comprehensive analysis to date.